Search for a trial

Risk factors for non-melanoma skin cancer (NMSC)
1. Skin carcinoma progression analyzed by genome-wide gene expression profiling and mimicked by validated organotypic in vitro human skin cancer models; towards an integrative system-biology approach and an in vitro screening method for targeted skin cancer therapies.
2. Genetic and environmental risk factors for the development of skin cancer in organ-transplant recipients.

Study 1:The ultimate goal is to abrogate or reduce the excessive burden of carcinomas in organ transplant patients. We aim to elucidate and establish consistent changes in genomic and expression (both mRNA and miRNA) profiles in the course of tumor…

A randomized clinical trial of excision versus photodynamic therapy in the treatment of Bowen's disease

Excision versus PDT in the tratment of Bowen's disease. What's the best therapy on behalve of recurrence rate, cosmetic outcome and cost-utility.

Three non-invasive Treatment Options for superficial basal cell carcinoma:
PDT vs. imiquimod vs. 5-fluorouracil

This research has the goal to determine which treatment is the most effective treatment in terms of prevention of treatment failure, in costs and has the patients preference when comparing PDT, Imiquimod and 5FU.

Identification of biological effects of bevacizumab in surgically resectable melanoma tumors.

To identify biological effects of bevacizumab therapy and to visualize distribution kinetics of 111In-bevacizumab with gamma-camera imaging.

Prospective randomised controlled study on imiquimod 5% cream as pre-treatment of Mohs micrographic surgery for primary large nodular basal cell carcinoma in the face.

Objectives1. Reduction of defect size after MMS with a pre-treatment with imiquimod 5% cream2. Reduction of tumour size of large nodular facial BCC, after pre-treatment with imiquimod 5% cream.3. Improvement of cosmetic results.4. Histological…